Exploration of the proliferative blood characteristics associated with Philadelphia-negative myeloproliferative neoplasms on diagnosis may be helpful in revealing early-prefibrotic primary myelofibrosis. Monitoring the levels of circulating CD34+ cells may provide a sensitive indicator of fibrotic evolution in polycythemia vera and primary myelofibrosis.
Int J Lab Hematol